[SYRS] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
07-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -14.58%
YoY- -17.84%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 7,802 5,699 508 893 0 317 0 -
PBT -23,813 -30,130 -19,729 -18,032 -15,302 -10,965 -10,689 14.26%
Tax 986 1,417 0 0 -390 0 0 -
NP -23,813 -30,130 -19,729 -18,032 -15,302 -10,965 -10,689 14.26%
Tax Rate - - - - - - - -
Total Cost 31,615 35,829 20,237 18,925 15,302 11,282 10,689 19.79%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -305.22 -528.69 -3,883.66 -2,019.26 0.00 -3,458.99 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -3.78 -4.91 -4.60 -5.35 -5.81 -4.69 -5.96 -7.30%
EPS Diluted -3.78 -4.91 -4.49 -5.34 -5.81 -4.69 -5.96 -7.30%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.